article_metadata: Neus Rabaneda-Lombarte Aina Teniente-Serra Anna Massuet-Vilamajó Cristina Ramo-Tello Silvia Presas-Rodríguez
article_metadata: 10.3389/fimmu.2024.1395749
article_metadata: Front Immunol
article_metadata: 2024 Jul 3:15:1395749.
article_metadata: alemtuzumab biomarkers case report immune subpopulations multiple sclerosis rebound tumefactive demyelinating lesions
article_metadata: CC BY
article_metadata: https://pubmed.ncbi.nlm.nih.gov/39021563/
article_metadata: Alemtuzumab / adverse effects Alemtuzumab / therapeutic use Biomarkers Magnetic Resonance Imaging Multiple Sclerosis, Relapsing-Remitting / drug therapy Multiple Sclerosis, Relapsing-Remitting / immunology
article_metadata: Alemtuzumab / adverse effects Alemtuzumab / therapeutic use Biomarkers Magnetic Resonance Imaging Multiple Sclerosis, Relapsing-Remitting / drug therapy Multiple Sclerosis, Relapsing-Remitting / immunology Case Reports Adult B-Lymphocytes / drug effects B-Lymphocytes / immunology Brain / diagnostic imaging Brain / immunology Brain / pathology Female Humans Th1 Cells / immunology Th17 Cells / immunology Alemtuzumab Biomarkers
article_metadata: PMC11251942
article_metadata: 39021563
article_metadata: Case report: tumefactive demyelinating lesions after the second cycle of alemtuzumab in multiple sclerosis; immune cell profile and biomarkers
article_metadata: 2024